← Leaderboards
James C M Brust
Albert Einstein College Of Medicine
$9,241,557
Attributed
$9,624,995
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,624,995 · 5
By mechanism
R01$8,071,005 · 3
K24$889,230 · 1
K23$664,760 · 1
Top collaborators
- Gary Maartens1 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Jacqueline Michele Achkar$9,972,918
Others in their field
Top investigators on “Resistance”
- Judith S. Currier · University Of California Los Angeles$243,611,225
- Gregory H Reaman · National Childhood Cancer Foundation$217,720,574
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$180,092,958
- Ralph Parchment · Leidos Biomedical Research, Inc.$149,556,948
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,991,858
- Peter C Adamson · National Childhood Cancer Foundation$113,790,601
Research focus
ResistanceExtreme Drug Resistant TuberculosisPharmaceutical PreparationsDrug ResistanceEpidemicTuberculosisSouth AfricaMultidrug-Resistant TuberculosisEnrollmentDrug KineticsDrug Resistance In TuberculosisRegimenTuberculosis TreatmentMycobacterium TuberculosisTuberculosis DrugsSuccessTreatment ProtocolsEffectivenessGenome SequencingMortalityTreatment ProgramAreaCaringExtensive Drug Resistance
Grant awards (24)
Therapeutic drug monitoring for linezolid in the treatment of rifampin-resistant tuberculosis: a pragmatic randomized controlled trial$766,877
R01 · FY2025 · AI · contact PI
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting$723,336
R01 · FY2025 · AI · contact PI
Mentoring of multidisciplinary global health research in tuberculosis and HIV$177,846
K24 · FY2025 · AI · contact PI
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting$745,231
R01 · FY2024 · AI · contact PI
Mentoring of multidisciplinary global health research in tuberculosis and HIV$177,846
K24 · FY2024 · AI · contact PI
Mentoring of multidisciplinary global health research in tuberculosis and HIV$177,846
K24 · FY2023 · AI · contact PI
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting$700,111
R01 · FY2022 · AI · contact PI
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting$699,465
R01 · FY2021 · AI · contact PI
Mentoring of multidisciplinary global health research in tuberculosis and HIV$177,846
K24 · FY2021 · AI · contact PI
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence setting$757,530
R01 · FY2020 · AI · contact PI
Mentoring of multidisciplinary global health research in tuberculosis and HIV$177,846
K24 · FY2020 · AI · contact PI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV$734,343
R01 · FY2019 · AI · contact PI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV$547,193
R01 · FY2018 · AI · contact PI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV$168,228
R01 · FY2018 · AI · contact PI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV$716,766
R01 · FY2017 · AI · contact PI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV$717,387
R01 · FY2016 · AI · contact PI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV$463,481
R01 · FY2015 · AI · contact PI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV$331,057
R01 · FY2015 · AI · contact PI
Integrated, Home-based Treatment for MDR TB and HIV in Rural South Africa$109,705
K23 · FY2014 · AI · contact PI
Integrated, Home-based Treatment for MDR TB and HIV in Rural South Africa$23,247
K23 · FY2014 · AI · contact PI
Integrated, Home-based Treatment for MDR TB and HIV in Rural South Africa$132,952
K23 · FY2013 · AI · contact PI
Integrated, Home-based Treatment for MDR TB and HIV in Rural South Africa$132,952
K23 · FY2012 · AI · contact PI
Integrated, Home-based Treatment for MDR TB and HIV in Rural South Africa$132,952
K23 · FY2011 · AI · contact PI
Integrated, Home-based Treatment for MDR TB and HIV in Rural South Africa$132,952
K23 · FY2010 · AI · contact PI